论文部分内容阅读
目的:探讨芬吗通在克罗米芬(CC)促排卵患者中改善子宫内膜厚度提高临床妊娠率的作用。方法:选择2013年6月至2014年6月就诊于承德市妇幼保健院生殖中心不明原因排卵障碍的不孕妇女340例。全部应用克罗米芬,随机应用芬吗通(研究组)、戊酸雌二醇对照组);观察两组病人排卵率、HCG日的子宫内膜厚度、子宫内膜类型、排卵后7d子宫内膜厚度、孕酮(P)水平、生化妊娠及临床妊娠率。结果:研究组组病人HCG日,子宫A型内膜所占比例、临床妊娠率高于对照组。结论:芬吗通纠正克罗米芬促排卵引起的子宫内膜发育不良,对提高临床妊娠效果明显。
Objective: To investigate the effect of FenTongTong in improving endometrial thickness and promoting clinical pregnancy rate in clomiphene citrate (ovulation) patients. Methods: From June 2013 to June 2014, 340 infertile women with unexplained ovulation disorders who attended the Reproductive Center of Chengde Maternal and Child Health Hospital were selected. All the patients were treated with clomiphene citrate, fentanypin (study group), estradiol valerate control group). The ovulation rate, HCG endometrial thickness, endometrial type, endometrium Thickness, progesterone (P) level, biochemical pregnancy and clinical pregnancy rate. Results: The study group HCG day, uterine type A endometrial proportion, clinical pregnancy rate was higher than the control group. Conclusion: Fentomeng Rectify clomiphene induced ovulation induced endometrial dysplasia, to improve clinical pregnancy effect is obvious.